DEVELOPING NOVEL THERAPEUTICS TARGETING UNDIFFERENTIATED AND CASTRATION-RESISTANT PROSTATE CANCER STEM CELLS

$596,639FY2014Department of the ArmyDOD

Health Research, Inc., Rockville MD

Investigators